Skip to content
value.today

Halo Neuro Inc.

Total raised
$27 M
2 rounds on record
Latest round
$18 M
Nov 2017
First round on record
Sep 2015
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Halo Neuro Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2017$18 MNo. 2$10 to $50 million

Halo Neuro Inc.: Raise no. 2, Nov 2017

Investors in this round

28 investors had bought by the notice of May 31, 2018: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $20 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Chao, M.D., M.S. · Executive Officer, Director
  • Andrew Firlik · Director
  • Heath Lukatch · Director
  • Peter Gotcher · Director
  • Peter Hebert · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel Chao, M.D., M.S., President and ceo. Newest notice filed May 31, 2018. Read the notice at the SEC.

equity, debtSEC
Sep 2015$9 MNo. 1$2 to $10 million

Halo Neuro Inc.: Raise no. 1, Sep 2015

Investors in this round

24 investors had bought by the notice of Mar 9, 2016: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $11 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Chao, M.D., M.S. · Executive Officer, Director
  • Amol Sarva · Director
  • Andrew Firlik · Director
  • Peter Hebert · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel Chao, M.D., M.S., President and ceo. Newest notice filed Mar 9, 2016. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Halo Neuro Inc. chose not to state its revenue in its newest notice of a funding round (May 2018).

    SEC Form D · May 2018

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · May 2018

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Halo Neuro Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Halo Neuro Inc.
NameRoleNamed in
Daniel Chao, M.D., M.S.Executive officerMay 2018
Andrew FirlikDirectorMay 2018
Daniel Chao, M.D., M.S.DirectorMay 2018
Heath LukatchDirectorMay 2018
Peter GotcherDirectorMay 2018
Peter HebertDirectorMay 2018
Amol SarvaDirectorMar 2016